Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the hugely contagious Omicron variant.Pfizer and its partner, BioNTech, announced the study on Tuesday.COVID-19 vaccine makers have been updating their shots to better match omicron in case global health authorities decide the change is needed.
Load More
Load More